Clinical Trial Update: A Multicenter Randomized Open-label Study of Chidamide Plus HD-DEX Versus HD-DEX in ITP [Phase 2]

View source ↗

Summary

A Phase 2 multicenter randomized open-label trial comparing chidamide plus high-dose dexamethasone (HD-DEX) to HD-DEX alone in thrombocytopenia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thrombocytopenia

Drugs mentioned

• Chidamide (chidamide)
• high-dose dexamethasone

Snippet

Sponsor: Shandong University | Conditions: Thrombocytopenia | Phase 2 | Status: UNKNOWN